What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?
Rheumatoid arthritis (RA) is an autoimmune disease characterised by persistent inflammation of the synovial joints as well as other tissues and organs. Left untreated, it can lead to joint damage, disability and even increased mortality. The disease is driven by inflammatory cytokines that contribut...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2024-10-01
|
| Sarja: | Therapeutic Advances in Musculoskeletal Disease |
| Linkit: | https://doi.org/10.1177/1759720X241283340 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|